Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors

These results suggest, together with an increased PD-L1 expression on MSI tumor cells, that the efficacy of immunotherapies in MSI CRC based on PD-1/PD-L1 blockade could also rely on a superior anti-tumor potential of PD-1<sup>+</sup> NK cells. Conversely, MSS CRC, in which tumor-associated PD-1<sup>+</sup> NK cells are scarce, could benefit more from immunotherapies blocking NKG2A and/or KIRs. Thus, novel approaches based on NK cell features related to CRC type, fully exploiting circulating and resident NK cell anti-tumor activity, could be key to next-generation therapies.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-06-18
DOI
https://doi.org/10.3389/fimmu.2025.1578444
Citations
3
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
2.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors

Mariella Della Chiesa, Fulvia Ortolani, Silvia Pesce, Valentina Obino et al.
3 citations
Frontiers in Immunology
Immune Cell Function and Interaction
2.39
article

Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1+ NK cells in microsatellite instability tumors

Mariella Della Chiesa, Fulvia Ortolani, Silvia Pesce, Valentina Obino, Simona Carlomagno, Simona Sivori, Matteo Bozzo, Simona Candiani, Mariangela Rutigliani, Marco Greppi, Matteo Clavarezza, Tania Buttiron Webber, Letizia Muccio, Andrea Barberis, Laura Paleari, Emanuela Marcenaro, E. Ciferri, Elisa Ferretti, Nicoletta Provinciali, Andrea DeCensi, Chiara Setti, Chiara Giordano, Marco Filauro, Agnese Solari
article en
3 citations

Abstract

These results suggest, together with an increased PD-L1 expression on MSI tumor cells, that the efficacy of immunotherapies in MSI CRC based on PD-1/PD-L1 blockade could also rely on a superior anti-tumor potential of PD-1<sup>+</sup> NK cells. Conversely, MSS CRC, in which tumor-associated PD-1<sup>+</sup> NK cells are scarce, could benefit more from immunotherapies blocking NKG2A and/or KIRs. Thus, novel approaches based on NK cell features related to CRC type, fully exploiting circulating and resident NK cell anti-tumor activity, could be key to next-generation therapies.

Frontiers in ImmunologyVol. 16
University of Udine (IT), Queen Mary University of London (GB), Ente Ospedaliero Ospedali Galliera (IT), Gibraltar Health Authority (GI), Ospedale Policlinico San Martino (IT), University of Genoa (IT)
Good health and well-being
Openalex Percentile: Top 11%
Immune Cell Function and Interaction
2.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.